Back to top
more

HCA Healthcare (HCA)

(Delayed Data from NYSE)

$322.16 USD

322.16
1,232,284

+0.43 (0.13%)

Updated Jul 19, 2024 04:00 PM ET

After-Market: $322.01 -0.15 (-0.05%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 7% (17 out of 250)

Industry: Medical - Hospital

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Kaibalya Pravo Dey headshot

Buying Tenet (THC) Pre-Q2 Earnings: A Prescription for Profits?

by Kaibalya Pravo Dey

Tenet Healthcare's (THC) second-quarter earnings are likely to have benefited from higher admissions, average length of stay and patient days.

Backlog Conversion Likely to Aid Medpace's (MEDP) Q2 Earnings

by Zacks Equity Research

Continued strength in backlog conversion rate is likely to have boosted Medpace's (MEDP) top line in the second quarter.

What's in Store for Texas Instruments (TXN) in Q2 Earnings?

by Zacks Equity Research

Texas Instruments' (TXN) second-quarter 2024 results are likely to reflect the adverse impacts of a weak demand environment and increasing manufacturing costs.

4 Healthcare Stocks Poised to Beat Q2 Earnings Estimates

by Zacks Equity Research

Expanding aging population and the increasing demand for affordable health products are likely to have boosted the performance of healthcare stocks in Q2. CI, UHS, HCA & THC are potential outperformers.

Will Clear Aligner Sales Drive Align Technology's (ALGN) Q2 Earnings?

by Zacks Equity Research

Align Technology's (ALGN) second-quarter results are likely to reflect the strength in its Clear Aligner and Systems & Services businesses.

Hologic's (HOLX) Surgical Business Set to Propel Q3 Earnings

by Zacks Equity Research

Hologic (HOLX) is likely to have delivered impressive performances across the GYN Surgical and Breast Health businesses in the third quarter of fiscal 2024.

Can HCA Healthcare (HCA) Beat Q2 Earnings on Growing Admissions?

by Zacks Equity Research

HCA Healthcare's (HCA) second-quarter earnings are likely to benefit from improved admissions and payer mix, partially offset by rising operating expenses.

Will Patient Volumes Drive Universal Health's (UHS) Q2 Earnings?

by Zacks Equity Research

Universal Health's (UHS) Q2 performance is likely to gain from strong performances in its Acute Care Hospital Services and Behavioral Health Care Services segments.

Tenet Healthcare (THC) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

Tenet (THC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's How Thermo Fisher (TMO) is Placed Ahead of Q2 Earnings

by Zacks Equity Research

Strength in Analytical Instrument and Laboratory Products and Services segments is likely to have driven Thermo Fisher's (TMO) second-quarter 2024 performance.

UnitedHealth Group (UNH) Q2 Earnings Beat on Strong Optum Unit

by Zacks Equity Research

UnitedHealth Group's (UNH) second-quarter earnings continue to be supported by strong Optum and UnitedHealthcare business lines. Rising medical costs partially offset the positives.

HCA Healthcare (HCA) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

HCA (HCA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

What Awaits Quest Diagnostics (DGX) in Q2 Earnings Release?

by Zacks Equity Research

Quest Diagnostics (DGX) is likely to have maintained its robust base business performance in the second quarter of 2024. However, nosediving COVID-19 testing revenues may limit growth.

Do Options Traders Know Something About HCA Healthcare (HCA) Stock We Don't?

by Zacks Equity Research

Investors need to pay close attention to HCA Healthcare (HCA) stock based on the movements in the options market lately.

Shilpa Mete headshot

4 GARP Stocks to Scoop up for Maximum Returns

by Shilpa Mete

Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. BAP, BAH, HUBB and HCA are some stocks that hold promise.

Select Medical (SEM) Expands Rehabilitation Services in Central PA

by Zacks Equity Research

Select Medical (SEM) and UPMC unveil a 20-bed satellite facility of Helen M. Simpson Rehabilitation Hospital in West Shore, thus enhancing specialized inpatient rehabilitation care in Central Pennsylvania.

Here's How Abbott (ABT) is Placed Ahead of Q2 Earnings Release

by Zacks Equity Research

Abbott Laboratories' (ABT) second-quarter 2024 results are likely to reflect broad-based strength across several businesses and solid progress in the pipeline.

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

by Zacks Equity Research

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

Sweta Killa headshot

5 Stocks Worth a Look From Leading Sectors This Earnings Season

by Sweta Killa

Apple (AAPL), HCA Healthcare (HCA), Expro International (XPRO), Churchill Downs (CHDN) and JPMorgan Chase (JPM) could make great plays as the second-quarter earnings season unfolds.

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

by Zacks Equity Research

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

Sanghamitra Saha headshot

2 Sector ETFs & Stocks to Gain Despite Soft June Jobs Data

by Sanghamitra Saha

The U.S. economy added 206,000 jobs in June 2024, slightly below a downwardly revised 218,000 in May and above forecasts of 190,000.

Will HCA (HCA) Beat Estimates Again in Its Next Earnings Report?

by Zacks Equity Research

HCA (HCA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Here's Why You Should Retain Ensign Group (ENSG) Stock Now

by Zacks Equity Research

Ensign Group (ENSG) remains well-poised for growth on the back of solid segmental contributions, an expanding healthcare portfolio and sound cash reserves.